Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 17

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 17
---
 the SEC at 100 F Street N.E. Washington, D.C. 20549, You can obtain copies from the public reference
room of the SEC at 100 F Street N.E. Washington, D.C. 20549, upon payment of certain fees. You can call the SEC at 1-800-732-0330 for
further information about the public reference room. We are also required to file electronic versions of these documents with the SEC,
which may be accessed through the SEC’s World Wide Web site at http://www.sec.gov. No dealer, salesperson or other person is authorized
to give any information or to make any representations other than those contained in this prospectus, and, if given or made, such information
or representations must not be relied upon as having been authorized by us. This prospectus does not constitute an offer to buy any security
other than the securities offered by this prospectus, or an offer to sell or a solicitation of an offer to buy any securities by any person
in any jurisdiction where such offer or solicitation is not authorized or is unlawful. Neither delivery of this prospectus nor any sale
hereunder shall, under any circumstances, create any implication that there has been no change in the affairs of our company since the
date hereof.

<div align='center'>8

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>

Item 3. Incorporation of Documents by Reference.

The Securities and Exchange Commission, or SEC,
allows us to incorporate by reference certain of our publicly filed documents into this prospectus, which means that such information
is considered part of this prospectus. Information that we file with the SEC subsequent to the date of this prospectus will automatically
update and supersede this information. We incorporate by reference the documents listed below and any future filings made with the SEC
under all documents subsequently filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until the selling stockholders
have sold all of the shares offered hereby or such shares have been deregistered.

| ● | The description of our common stock contained in our Registration Statement on Form 8-A filed with the SEC on February 1, 2019 (File No. 001-38793), including any amendment or report filed for the purpose of updating such description. In addition, a Form 8-A filed on December 30, 2020, contains a description of certain